Trading Signals: TYME Stock Price Prediction and Forecast (Tue. Aug. 15, 2017 - Fri. Jan. 26, 2018)(Tyme Technologies)
| Market is closed on Fri. Apr. 16, 2021 | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0% (three month average) | RSI | | Latest Price | $(0%) | Stocks Behave Similarly | Similar Stock List | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support TYME advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting TYME price | TYME will advance at least -0% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | | | | Market Trend Strength | 0% (StdDev 0%) | Hourly BBV | -0.1 () | Intraday Trend | NAN% | | | |
|
Tyme Technologies, Inc., is an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have low toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, the Company's therapeutic approach is designed to take advantage of a cancer cell's innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body's natural immune system. With the development of TYME-18 and TYME-19, the Company believes that it is also emerging as a leader in the development of bile acids as potential therapies for cancer and COVID-19. |